Home
StockRanks™
Platform
Insights
Research & Discuss
Editorial & Community
Learn & Improve
Webinars & Masterclasses
Stockopedia Academy
Reviews
Pricing
Get started
Log in
Sectors
Healthcare
Biotechnology & Medical Research
Rapt Therapeutics
RAPT —
Rapt Therapeutics
News Story
$57.96
0.00
0.00%
Last trade -
00:00
Healthcare
Speculative
Mid Cap
Momentum Trap
Market Cap
$1.68bn
Enterprise Value
$1.52bn
Revenue
Quality
Value
Momentum
Stock
Rank
™
StockReport™
Accounts
Balance sheet
Income statement
Cashflow statement
Dividend summary
News
RAPT Dividends
StockReport™
Balance sheet
Income statement
Cashflow
News
RAPT Dividends
All News
Brief: Rapt Therapeutics Q4 Net Income USD -30.876 Million
Rapt Therapeutics
07/03/2024 13:00
Mar 07 (Reuters) - Rapt Therapeutics Q4 basic EPS USD -0.8
Recent news on Rapt Therapeutics
See all news
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:08 PM
03/03/2026 20:08
NASDAQ RESUMED AT 03:08 PM
03/03/2026 20:08
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:03 PM
03/03/2026 20:03
NASDAQ RESUMED AT 03:03 PM
03/03/2026 20:03
NASDAQ RESUMED AT 02:58 PM
03/03/2026 19:58